1 |
周学东. 牙体牙髓病学[M]. 5版.北京: 人民卫生出版社, 2020: 167.
|
|
Zhou XD. Operative dentistry and endodontics[M]. 5th ed. Beijing: People’s Medical Publishing House, 2020: 167.
|
2 |
AAE position statement on vital pulp therapy[J]. J Endod, 2021, 47(9): 1340-1344.
|
3 |
Guideline on pulp therapy for primary and immature permanent teeth[J]. Pediatr Dent, 2016, 38(6): 280-288.
|
4 |
Duncan HF, Galler KM, Tomson PL, et al. European Society of Endodontology position statement: management of deep caries and the exposed pulp[J]. Int Endod J, 2019, 52(7): 923-934.
|
5 |
Ricucci D, Loghin S, Siqueira JF Jr. Correlation bet-ween clinical and histologic pulp diagnoses[J]. J Endod, 2014, 40(12): 1932-1939.
|
6 |
Asgary S, Eghbal MJ, Ghoddusi J. Two-year results of vital pulp therapy in permanent molars with irreversible pulpitis: an ongoing multicenter randomized clinical trial[J]. Clin Oral Invest, 2014, 18(2): 635-641.
|
7 |
Asgary S, Eghbal MJ, Fazlyab M, et al. Five-year results of vital pulp therapy in permanent molars with irrever-sible pulpitis: a non-inferiority multicenter randomized clinical trial[J]. Clin Oral Invest, 2015, 19(2): 335-341.
|
8 |
Taha NA, Khazali MA. Partial pulpotomy in mature permanent teeth with clinical signs indicative of irreversible pulpitis: a randomized clinical trial[J]. J Endod, 2017, 43(9): 1417-1421.
|
9 |
Taha NA, Abdulkhader SZ. Full pulpotomy with biodentine in symptomatic young permanent teeth with carious exposure[J]. J Endod, 2018, 44(6): 932-937.
|
10 |
Uesrichai N, Nirunsittirat A, Chuveera P, et al. Partial pulpotomy with two bioactive cements in permanent tee-th of 6- to 18-year-old patients with signs and symptoms indicative of irreversible pulpitis: a noninferiority randomized controlled trial[J]. Int Endod J, 2019, 52(6): 749-759.
|
11 |
彭楚芳, 赵玉鸣, 杨媛, 等. 三氧化矿物凝聚体牙髓切断术治疗年轻恒牙不可复性牙髓炎的初步研究[J]. 中华口腔医学杂志, 2015, 50(12): 715-719.
|
|
Peng CF, Zhao YM, Yang Y, et al. Mineral trioxide aggragate pulpotomy for the treatment of immature permanent teeth with irreversible pulpitis: a preliminary clinical study[J]. Chin J Stomatol, 2015, 50(12): 715-719.
|
12 |
肖文, 史文涛, 汪俊. 炎性活髓保存在年轻恒牙不可逆性牙髓炎及根尖周炎治疗中的应用[J]. 中华口腔医学杂志, 2022, 57(3): 287-291.
|
|
Xiao W, Shi WT, Wang J. Study of vital inflamed pulp therapy in immature permanent teeth with irreversible pulpitis and apical periodontitis[J]. Chin J Stomatol, 2022, 57(3): 287-291.
|
13 |
Linsuwanont P, Wimonsutthikul K, Pothimoke U, et al. Treatment outcomes of mineral trioxide aggregate pul-potomy in vital permanent teeth with carious pulp exposure: the retrospective study[J]. J Endod, 2017, 43(2): 225-230.
|
14 |
Asgary S, Eghbal MJ. Treatment outcomes of pulpotomy in permanent molars with irreversible pulpitis using biomaterials: a multi-center randomized controlled trial[J]. Acta Odontol Scand, 2013, 71(1): 130-136.
|
15 |
Taha NA, Abdelkhader SZ. Outcome of full pulpotomy using Biodentine in adult patients with symptoms indicative of irreversible pulpitis[J]. Int Endod J, 2018, 51(8): 819-828.
|
16 |
Asgary S, Eghbal MJ, Bagheban AA. Long-term outcomes of pulpotomy in permanent teeth with irreversible pulpitis: a multi-center randomized controlled trial[J]. Am J Dent, 2017, 30(3): 151-155.
|
17 |
Smith AJ, Duncan HF, Diogenes A, et al. Exploiting the bioactive properties of the dentin-pulp complex in regenerative endodontics[J]. J Endod, 2016, 42(1): 47-56.
|
18 |
Memarpour M, Fijan S, Asgary S, et al. Calcium-enriched mixture pulpotomy of primary molar teeth with irreversible pulpitis. A clinical study[J]. Open Dent J, 2016, 10: 43-49.
|
19 |
Asgary S, Sarraf Shirazi A, Sabbagh S. Management of primary molars with irreversible pulpitis employing tampon pulpotomy: report of three cases with 34-month mean follow-up[J]. Clin Case Rep, 2021, 9(4): 2289-2294.
|
20 |
Ricucci D, Siqueira JF Jr, Li Y, et al. Vital pulp therapy: histopathology and histobacteriology-based guidelines to treat teeth with deep caries and pulp exposure[J]. J Dent, 2019, 86: 41-52.
|
21 |
Aaminabadi NA, Parto M, Emamverdizadeh P, et al. Pulp bleeding color is an indicator of clinical and histohematologic status of primary teeth[J]. Clin Oral Investig, 2017, 21(5): 1831-1841.
|
22 |
Wolters WJ, Duncan HF, Tomson PL, et al. Minimally invasive endodontics: a new diagnostic system for assessing pulpitis and subsequent treatment needs[J]. Int Endod J, 2017, 50(9): 825-829.
|
23 |
Rajasekharan S, Martens LC, Vandenbulcke J, et al. Efficacy of three different pulpotomy agents in primary molars: a randomized control trial[J]. Int Endod J, 2017, 50(3): 215-228.
|
24 |
Çelik BN, Mutluay MS, Arıkan V, et al. The evaluation of MTA and Biodentine as a pulpotomy materials for carious exposures in primary teeth[J]. Clin Oral Investig. 2019, 23(2): 661-666.
|
25 |
Rao Q, Kuang J, Mao C, et al. Comparison of iRoot BP Plus and calcium hydroxide as pulpotomy materials in permanent incisors with complicated crown fractures: a retrospective study[J]. J Endod, 2020, 46(3): 352-357.
|
26 |
Yang Y, Xia B, Xu Z, et al. The effect of partial pulpotomy with iRoot BP Plus in traumatized immature permanent teeth: a randomized prospective controlled trial[J]. Dent Traumatol, 2020, 36(5): 518-525.
|
27 |
Hu X, Li Y, Xu J, et al. Immature permanent incisors with complicated crown fractures treated with partial pulpotomy using white mineral trioxide aggregate and IRoot BP plus-a retrospective long-term study[J]. Dent Traumatol, 2023, 39(2): 165-172.
|
28 |
Hafez AA, Cox CF, Tarim B, et al. An in vivo evaluation of hemorrhage control using sodium hypochlorite and direct capping with a one- or two-component adhesive system in exposed nonhuman primate pulps[J]. Quintessence Int, 2002, 33(4): 261-272.
|